14-95094126-T-C
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PM5PP2PP3_StrongPP5
The ENST00000343455.8(DICER1):āc.5126A>Gā(p.Asp1709Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,888 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D1709N) has been classified as Pathogenic.
Frequency
Consequence
ENST00000343455.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DICER1 | NM_177438.3 | c.5126A>G | p.Asp1709Gly | missense_variant | 24/27 | ENST00000343455.8 | NP_803187.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DICER1 | ENST00000343455.8 | c.5126A>G | p.Asp1709Gly | missense_variant | 24/27 | 1 | NM_177438.3 | ENSP00000343745 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461888Hom.: 0 Cov.: 33 AF XY: 0.00000138 AC XY: 1AN XY: 727246
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
DICER1-related tumor predisposition Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 20, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant disrupts the p.Asp1709 amino acid residue in DICER1, a functionally conserved metal-binding residue within the RNase IIIb domain (PMID: 22187960, 26408257, 23132766). Other variants that disrupt this residue have been reported in individuals with DICER1-related conditions (PMID: 22187960, 26475046, 24839956, 24676357). This suggests that this residue is clinically significant, and that variants that disrupt this residue may be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt DICER1 protein function. ClinVar contains an entry for this variant (Variation ID: 477242). This variant has been reported as mosaic in an individual with pleuropulmonary blastoma (PMID: 26925222). This variant also has been reported as a somatic variant in DICER1-related tumors (PMID: 22187960, 26555935, 27459524). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 1709 of the DICER1 protein (p.Asp1709Gly). - |
Pathogenic, criteria provided, single submitter | curation | Foulkes Cancer Genetics LDI, Lady Davis Institute for Medical Research | Jul 01, 2019 | ACMG criteria met: PS2, PS3, PM1, PM2, PP4 - |
Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 21, 2019 | The p.D1709G variant (also known as c.5126A>G), located in coding exon 23 of the DICER1 gene, results from an A to G substitution at nucleotide position 5126. The aspartic acid at codon 1709 is replaced by glycine, an amino acid with similar properties. In a study of 124 children with pleuropulmonary blastoma, this variant was reported as a germline mosaic finding in one patient, who had small intestinal polyps, pleuropulmonary blastoma, and cystic nephroma (Brenneman M et al. F1000Res. 2015 Jul;4:214). This variant has been reported as a somatic finding in many studies, including studies of ovarian sex cord stromal tumors and multinodular goiters (de Kock L et al. Hum. Mutat. 2019 11;40:1939-1953). This alteration is located in the RNase IIIb domain of the DICER1 protein and variants at this codon have been characterized as somatic hotspot mutations (Foulkes WD et al. Nat. Rev. Cancer. 2014 Oct;14:662-72). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at